BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related ...
Hosted on MSN
BioLife Solutions raises 2025 revenue guidance to $100M–$103M as cell processing momentum accelerates
CEO Roderick de Greef reported, "We delivered another strong quarter as our team continues to execute and build on the momentum established over the last several quarters." Cell processing revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results